Analyzing Applied DNA Sciences (NASDAQ:APDN) & Data443 Risk Mitigation (OTCMKTS:ATDS)

Insider & Institutional Ownership

22.2% of Applied DNA Sciences shares are owned by institutional investors. 0.0% of Applied DNA Sciences shares are owned by insiders. Comparatively, 36.4% of Data443 Risk Mitigation shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Applied DNA Sciences and Data443 Risk Mitigation”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Applied DNA Sciences $3.79 million 0.45 -$6.99 million ($923.81) 0.00
Data443 Risk Mitigation $4.87 million 0.04 -$6.09 million N/A N/A

Data443 Risk Mitigation has higher revenue and earnings than Applied DNA Sciences.

Volatility & Risk

Applied DNA Sciences has a beta of -0.02, meaning that its share price is 102% less volatile than the S&P 500. Comparatively, Data443 Risk Mitigation has a beta of 41.29, meaning that its share price is 4,029% more volatile than the S&P 500.

Profitability

This table compares Applied DNA Sciences and Data443 Risk Mitigation’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Applied DNA Sciences -399.91% -124.61% -94.64%
Data443 Risk Mitigation -81.94% N/A -65.80%

Summary

Data443 Risk Mitigation beats Applied DNA Sciences on 7 of the 9 factors compared between the two stocks.

About Applied DNA Sciences

(Get Free Report)

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

About Data443 Risk Mitigation

(Get Free Report)

Data443 Risk Mitigation, Inc. provides data security and privacy management solutions in the United States. The company offers Cyren Threat Intelligence Service that provides security, response, software, and services; Cyren Inbox Security for Microsoft 365, which prevents user access to malicious links and attachments; Ransomware Recovery Manager to recover a workstation upon infection to the last known business-operable state; Data Identification Manager, a data classification and governance technology; Data Archive Manager for enterprise data retention management and archiving; and Sensitive Content Manager, a cloud-based platform for managing, protecting, and distributing digital content. It also provides Data Placement Manager, a data transport, transformation, and delivery product; Access Control Manager that enables access controls across various platforms at scale for internal client systems and commercial public cloud platforms; Blockchain Protection Manager, which protects blockchain transactions from inadvertent disclosure and data leaks; and Global Privacy Manager, a privacy compliance and consumer loss mitigation platform. In addition, the company offers IntellyWP to enhance the user experience for content management platform; Chat History Scanner, which scans chat messages for compliance, security, personally identifiable information, personal information, payment card industry information, and custom keywords; and GDPR Framework, CCPA Framework, and LGPD Framework WordPress Plugins that enables organizations’ compliance on privacy rules and regulations. It serves the government, financial services, healthcare, manufacturing, retail, technology, and telecommunications sectors. The company was formerly known as LandStar, Inc. and changed its name to Data443 Risk Mitigation, Inc. in October 2019. Data443 Risk Mitigation, Inc. was founded in 1998 and is headquartered in Research Triangle Park, North Carolina.

Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.